The therapies by Regeneron and Eli Lilly are not effective against the omicron variant, officials said.
FDA ends for now use of two monoclonal antibodies, spurring a halt in federal shipments of the covid-19 treatments
The therapies by Regeneron and Eli Lilly are not effective against the omicron variant, officials said.